GDA Antibody (Center)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, E |
---|---|
Primary Accession | Q9Y2T3 |
Other Accession | NP_004284.1 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 51003 Da |
Antigen Region | 164-193 aa |
Gene ID | 9615 |
---|---|
Other Names | Guanine deaminase, Guanase, Guanine aminase, Guanine aminohydrolase, GAH, p51-nedasin, GDA, KIAA1258 |
Target/Specificity | This GDA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 164-193 amino acids from the Central region of human GDA. |
Dilution | WB~~1:1000 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | GDA Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | GDA (HGNC:4212) |
---|---|
Function | Catalyzes the hydrolytic deamination of guanine, producing xanthine and ammonia. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene is an enzyme that catalyzes the hydrolytic deamination of guanine, producing xanthine and ammonia. It is also known as a cytosolic regulator of PSD-95 postsynaptic targeting.
References
Martins-de-Souza, D., et al. J Psychiatr Res 44(16):1176-1189(2010)
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :
Lamesch, P., et al. Genomics 89(3):307-315(2007)
Kubo, K., et al. J. Med. Invest. 53 (3-4), 264-270 (2006) :
Sannomiya, K., et al. J. Med. Invest. 53 (3-4), 246-254 (2006) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.